Clinical Trials for NiKang Therapeutics

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: NiKang Therapeutics

Clinical Trials (5)

NCT07029399
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
PHASE1Recruiting
205 participants
Started: Mar 25, 2025 · Completed: Dec 31, 2027
7 conditions1 sponsor8 locations
NCT06586957
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
PHASE1Recruiting
150 participants
Started: Sep 19, 2024 · Completed: May 31, 2029
28 conditions1 sponsor14 locations
NCT05935748
Ph2 Study NKT2152 with Palbociclib & Sasanlimab in Subjects with Advanced Clear Cell Renal Cell Carcinoma (ccRcc)
PHASE2Active, not recruiting
172 participants
Started: Jul 28, 2023 · Completed: Jun 30, 2026
21 conditions2 sponsors8 locations
NCT05119335
A Study of NKT2152, a HIF2α Inhibitor, in Patients with Advanced Clear Cell Renal Cell Carcinoma
PHASE1/PHASE2Active, not recruiting
128 participants
Started: Oct 26, 2021 · Completed: Sep 30, 2026
17 conditions1 sponsor13 locations
NCT04524871
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)
PHASE1/PHASE2Recruiting
518 participants
Started: Nov 1, 2020 · Completed: Dec 31, 2026
1 condition5 sponsors33 locations